Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
Fuente:
PubMed
Guardado en:
| Autores principales: | Cao, Yin, Huang, Sen, He, Yaohui, Zhang, Yuxiang, Chen, Simian, Huang, Mengxian, He, Fengming, Chen, Shutong, Wang, Di, Yang, Ziying, Zhao, Xinwei, Wang, Xiumin, Wu, Zhen, Ao, Mingtao, Qiu, Yingkun, Fang, Meijuan |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Bioorganic chemistry
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
por: Chen, Xiaohui, et al.
Publicado: (2025)
por: Chen, Xiaohui, et al.
Publicado: (2025)
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
por: Du, Lin, et al.
Publicado: (2025)
por: Du, Lin, et al.
Publicado: (2025)
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
por: Mao, Churu, et al.
Publicado: (2024)
por: Mao, Churu, et al.
Publicado: (2024)
Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.
por: Wang, Lijun, et al.
Publicado: (2026)
por: Wang, Lijun, et al.
Publicado: (2026)
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.
por: Mao, Churu, et al.
Publicado: (2026)
por: Mao, Churu, et al.
Publicado: (2026)
Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
por: Fang, Zhangyun, et al.
Publicado: (2026)
por: Fang, Zhangyun, et al.
Publicado: (2026)
Pyrimidine Nucleosides, Benzoic Acid Derivative, and Bipyridine From the Marine-Derived Streptomyces Sp. DS52.
por: Xia, Meng-de, et al.
Publicado: (2025)
por: Xia, Meng-de, et al.
Publicado: (2025)
Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors.
por: Malosse, Killian, et al.
Publicado: (2025)
por: Malosse, Killian, et al.
Publicado: (2025)
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.
por: Tisseur, Lhana, et al.
Publicado: (2025)
por: Tisseur, Lhana, et al.
Publicado: (2025)
Sclerohumins G-L: Selective cytotoxic diterpenoids featuring a 4/9-fused ring system from the soft coral Sclerophytum humesi.
por: Luu, Phuong Vu, et al.
Publicado: (2026)
por: Luu, Phuong Vu, et al.
Publicado: (2026)
Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.
por: Bourg, Stéphane, et al.
Publicado: (2026)
por: Bourg, Stéphane, et al.
Publicado: (2026)
Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer.
por: Xu, Chenmeng, et al.
Publicado: (2025)
por: Xu, Chenmeng, et al.
Publicado: (2025)
Ircindrimanes A-I, nine undescribed meroterpenoids with cytotoxic activities from the marine sponge Ircinia sp.
por: Zhang, Wenjie, et al.
Publicado: (2025)
por: Zhang, Wenjie, et al.
Publicado: (2025)
Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1.
por: Tao, Xiaoyu, et al.
Publicado: (2025)
por: Tao, Xiaoyu, et al.
Publicado: (2025)
Synthesis of mitochondria-targeted podophyllotoxin derivatives for the imaging and antiproliferation of liver cancer.
por: Xu, Chenmeng, et al.
Publicado: (2026)
por: Xu, Chenmeng, et al.
Publicado: (2026)
Design and Synthesis of Marine Sarocladione Derivatives with Potential Anticancer Activity.
por: Liu, Xiao-Mei, et al.
Publicado: (2026)
por: Liu, Xiao-Mei, et al.
Publicado: (2026)
Aspirin-Inspired 6-O-Carboxymethyl-N-Acetylglucosamine: A potent antitumor agent with enhanced efficacy.
por: Qiao, Ziwen, et al.
Publicado: (2025)
por: Qiao, Ziwen, et al.
Publicado: (2025)
Epac (RAPGEF3) promotes betaglycan expression to mediate ciprofloxacin-induced suppression of cancer cell migration and metastasis: Mechanistic insights and drug repurposing potential.
por: Liu, Hui-Pu, et al.
Publicado: (2025)
por: Liu, Hui-Pu, et al.
Publicado: (2025)
Target Screening and Validation of the Antitumor Effect of Saponin Extract From Holothuria leucospilota.
por: Xu, Fuju, et al.
Publicado: (2025)
por: Xu, Fuju, et al.
Publicado: (2025)
Cytotoxicity, apoptosis, molecular docking, and molecular dynamics study of novel compounds of Sulfamide derivatives coupled with DHP scaffolds as potent inhibitors of the MCF-7, A549, SKOV-3, and EA. yh926 carcinoma cells.
por: Abdulrasool, Amjed, et al.
Publicado: (2026)
por: Abdulrasool, Amjed, et al.
Publicado: (2026)
Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer.
por: Wang, Zuo-Jun, et al.
Publicado: (2024)
por: Wang, Zuo-Jun, et al.
Publicado: (2024)
Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue.
por: Zhao, Xiuhe, et al.
Publicado: (2024)
por: Zhao, Xiuhe, et al.
Publicado: (2024)
Oxalicpyridones A-D, 2-pyridone alkaloids from a marine-derived fungus Penicillium oxalicum suppressing proliferation and metastasis against small cell lung cancer.
por: Chen, Xiangliu, et al.
Publicado: (2026)
por: Chen, Xiangliu, et al.
Publicado: (2026)
Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming.
por: Marquez, Jubert, et al.
Publicado: (2026)
por: Marquez, Jubert, et al.
Publicado: (2026)
Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation.
por: Yu, Jing, et al.
Publicado: (2026)
por: Yu, Jing, et al.
Publicado: (2026)
Preliminary Insights Into the Combined Antitumor Efficacy of Onco-VV-TT and Natural Killer Cells in Glioblastoma.
por: Mirbahari, Seyedeh Nasim, et al.
Publicado: (2026)
por: Mirbahari, Seyedeh Nasim, et al.
Publicado: (2026)
Anticancer Effects of Monacolin X Against Human Liver Cancer Cell Line: Exploring the Apoptosis Using AO/EB and DCFHDA Fluorescent Staining.
por: Jayaraman, Vennila, et al.
Publicado: (2025)
por: Jayaraman, Vennila, et al.
Publicado: (2025)
Total Synthesis of Nocarterphenyl A, 2-Dehydroxymethylnocarterphenyl A and Nocarterphenyl D Produced by Marine spp.
por: Xu, Quan, et al.
Publicado: (2025)
por: Xu, Quan, et al.
Publicado: (2025)
Discovery of novel ten-membered lactones as osteoblastogenesis agents targeting Wnt/β-catenin signaling pathway.
por: Zhai, Yi-Jie, et al.
Publicado: (2026)
por: Zhai, Yi-Jie, et al.
Publicado: (2026)
Undescribed alkaloids, peptides and polyketides from marine sediment-derived fungus Aspergillus terreus PPS1.
por: Zheng, Yao-Yao, et al.
Publicado: (2025)
por: Zheng, Yao-Yao, et al.
Publicado: (2025)
Repurposing Lamivudine: A novel therapeutic strategy for ischemic stroke targeting the glycolytic enzyme Pgk1.
por: Liu, Jingjing, et al.
Publicado: (2026)
por: Liu, Jingjing, et al.
Publicado: (2026)
Inhibition of Na,K -ATPase enzyme by tetrodotoxin extract in the breast tumor xenograft Balb/c nu mouse model.
por: Ahrari, Ameneh, et al.
Publicado: (2025)
por: Ahrari, Ameneh, et al.
Publicado: (2025)
Total syntheses of Kavaratamide A and 5--Kavaratamide A.
por: Ren, Tieshun, et al.
Publicado: (2025)
por: Ren, Tieshun, et al.
Publicado: (2025)
Prediction of newly synthesized heparin mimic's effects as heparanase inhibitor in cancer treatments via variational quantum neural networks.
por: Kocabay, Samet, et al.
Publicado: (2025)
por: Kocabay, Samet, et al.
Publicado: (2025)
Tumor Microenvironment-Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer.
por: Zhu, Zihan, et al.
Publicado: (2025)
por: Zhu, Zihan, et al.
Publicado: (2025)
Biogenic gold nanoparticles synthesized from Caulerpa sertularioides: A green approach for antioxidant, antibacterial and anticancer applications.
por: Sivakumar, Vibitha Sri, et al.
Publicado: (2025)
por: Sivakumar, Vibitha Sri, et al.
Publicado: (2025)
Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UC.
por: Guo, Mi, et al.
Publicado: (2025)
por: Guo, Mi, et al.
Publicado: (2025)
Suaeglaucin C: a new coumaronochromone isolated from .
por: Jia, Jia, et al.
Publicado: (2026)
por: Jia, Jia, et al.
Publicado: (2026)
Integrating experimental findings and machine learning models to predict the anticancer potential of newly synthesized oversulfated fucoidan.
por: Kocabay, Samet, et al.
Publicado: (2026)
por: Kocabay, Samet, et al.
Publicado: (2026)
Metabolic Blockade-Based Genome Mining of SCSIO 07745: Discovery and Biosynthetic Pathway of Aminoquinolinone Alkaloids Bearing 6/6/5 Tricyclic and 6/6/6/5 Tetracyclic Scaffolds.
por: Li, Kunlong, et al.
Publicado: (2025)
por: Li, Kunlong, et al.
Publicado: (2025)
Ejemplares similares
-
Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
por: Chen, Xiaohui, et al.
Publicado: (2025) -
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
por: Du, Lin, et al.
Publicado: (2025) -
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
por: Mao, Churu, et al.
Publicado: (2024) -
Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.
por: Wang, Lijun, et al.
Publicado: (2026) -
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.
por: Mao, Churu, et al.
Publicado: (2026)